Mutations that occur outside the protein kinase domain also play a role in the activation of RTKs, such as ERBB3 mutations, which promote the growth of colonic cells48 and ERBB4 mutations, which promote an increase in the kinase activity and transformation ability in melanoma cells49. The gene discussed is ERBB3; the disease is melanoma.